Expensify (EXFY) Competitors $2.22 0.00 (0.00%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$2.27 +0.05 (+2.25%) As of 07/25/2025 06:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock EXFY vs. CGNT, DOMO, VMEO, RDVT, PUBM, RZLV, WEAV, OSPN, DH, and CANGShould you be buying Expensify stock or one of its competitors? The main competitors of Expensify include Cognyte Software (CGNT), Domo (DOMO), Vimeo (VMEO), Red Violet (RDVT), PubMatic (PUBM), Rezolve AI (RZLV), Weave Communications (WEAV), ONESPAN (OSPN), Definitive Healthcare (DH), and Cango (CANG). These companies are all part of the "computer software" industry. Expensify vs. Its Competitors Cognyte Software Domo Vimeo Red Violet PubMatic Rezolve AI Weave Communications ONESPAN Definitive Healthcare Cango Expensify (NASDAQ:EXFY) and Cognyte Software (NASDAQ:CGNT) are both small-cap computer software companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, institutional ownership, analyst recommendations and risk. Does the media refer more to EXFY or CGNT? In the previous week, Expensify had 1 more articles in the media than Cognyte Software. MarketBeat recorded 3 mentions for Expensify and 2 mentions for Cognyte Software. Cognyte Software's average media sentiment score of 0.93 beat Expensify's score of 0.63 indicating that Cognyte Software is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Expensify 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cognyte Software 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is EXFY or CGNT more profitable? Cognyte Software has a net margin of -2.18% compared to Expensify's net margin of -6.66%. Cognyte Software's return on equity of -3.53% beat Expensify's return on equity.Company Net Margins Return on Equity Return on Assets Expensify-6.66% -7.60% -5.16% Cognyte Software -2.18%-3.53%-1.56% Which has higher valuation and earnings, EXFY or CGNT? Expensify has higher earnings, but lower revenue than Cognyte Software. Cognyte Software is trading at a lower price-to-earnings ratio than Expensify, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExpensify$139.24M1.28-$10.06M-$0.09-24.67Cognyte Software$350.63M1.91-$12.05M-$0.11-84.55 Do insiders and institutionals hold more shares of EXFY or CGNT? 68.4% of Expensify shares are held by institutional investors. Comparatively, 72.9% of Cognyte Software shares are held by institutional investors. 12.3% of Expensify shares are held by insiders. Comparatively, 62.7% of Cognyte Software shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Do analysts recommend EXFY or CGNT? Expensify presently has a consensus target price of $4.00, suggesting a potential upside of 80.18%. Given Expensify's stronger consensus rating and higher probable upside, research analysts clearly believe Expensify is more favorable than Cognyte Software.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Expensify 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Cognyte Software 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk & volatility, EXFY or CGNT? Expensify has a beta of 1.75, indicating that its share price is 75% more volatile than the S&P 500. Comparatively, Cognyte Software has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500. SummaryExpensify and Cognyte Software tied by winning 8 of the 16 factors compared between the two stocks. Get Expensify News Delivered to You Automatically Sign up to receive the latest news and ratings for EXFY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EXFY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EXFY vs. The Competition Export to ExcelMetricExpensifyFinancial Transaction Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$178.43M$34.25B$19.00B$9.50BDividend YieldN/A2.38%2.73%4.01%P/E Ratio-24.6729.5429.5320.05Price / Sales1.2812.8050.2790.07Price / CashN/A19.0627.3958.56Price / Book1.347.586.265.87Net Income-$10.06M$1.11B$197.18M$258.55M7 Day Performance4.72%-0.07%1.55%3.74%1 Month Performance-10.12%-2.06%5.45%11.75%1 Year Performance12.12%32.25%26.56%18.03% Expensify Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EXFYExpensify2.581 of 5 stars$2.22flat$4.00+80.2%+16.2%$178.43M$139.24M-24.67140News CoverageAnalyst UpgradeCGNTCognyte Software1.926 of 5 stars$9.16-0.2%N/A+23.8%$661.48M$350.63M-83.271,623DOMODomo3.5391 of 5 stars$15.81-2.9%$13.14-16.9%+89.3%$655.43M$317.04M-8.37920High Trading VolumeVMEOVimeo3.8875 of 5 stars$4.03+2.0%$7.35+82.4%+7.3%$650.74M$417.01M40.301,102Positive NewsRDVTRed Violet0.8602 of 5 stars$45.48+0.1%N/A+68.0%$634.02M$75.19M74.56140Positive NewsPUBMPubMatic3.2683 of 5 stars$12.79+2.4%$18.38+43.7%-42.4%$606.11M$291.26M159.891,049Insider TradeRZLVRezolve AI2.2313 of 5 stars$2.70-4.3%$6.00+122.2%N/A$587.29M$190K0.00N/ANews CoverageHigh Trading VolumeWEAVWeave Communications3.5627 of 5 stars$7.81+0.5%$16.10+106.3%-24.3%$584.16M$204.31M-19.04890News CoverageUpcoming EarningsOSPNONESPAN4.9201 of 5 stars$14.91-0.9%$19.50+30.8%+5.2%$574.99M$243.18M10.14790Positive NewsDHDefinitive Healthcare1.2457 of 5 stars$3.99+3.9%$5.10+27.8%-31.4%$570.79M$252.20M-0.91970CANGCango2.9917 of 5 stars$5.02-5.6%N/A+157.5%$552.12M$110.21M-250.872,350Analyst ForecastAnalyst RevisionHigh Trading Volume Related Companies and Tools Related Companies Cognyte Software Competitors Domo Competitors Vimeo Competitors Red Violet Competitors PubMatic Competitors Rezolve AI Competitors Weave Communications Competitors ONESPAN Competitors Definitive Healthcare Competitors Cango Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EXFY) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Expensify, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Expensify With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EXFY Stock Alerts